RBC Cuts Perspective Therapeutics to Sector Perform, Lowers Target to $4
RBC cut its rating from Outperform to Sector Perform and reduced its price target from $14 to $4.
Story updates
10:28:55 AM UTC
SquawkNews
06:28 AM EDT, 10/26/2026 (MT Newswires) -- Perspective Therapeutics (CATX) has an average rating of